Buch, Englisch, 238 Seiten, Format (B × H): 170 mm x 244 mm, Gewicht: 598 g
Reihe: Milestones in Drug Therapy
Buch, Englisch, 238 Seiten, Format (B × H): 170 mm x 244 mm, Gewicht: 598 g
Reihe: Milestones in Drug Therapy
ISBN: 978-3-7643-2196-3
Verlag: Springer
During recent years the field of effective anticancer agents has substantially increased. The use of chemotherapy has been accepted as a standard therapy for an expanding number of tumour types and stages, while many new agents are being investigated when standard therapy is lacking or failing. Apart from new targets for anticancer agents, attention is also focused on improving efficacy and tolerability of existing compounds.
This topical volume provides an up-to-date overview of clinically relevant data on anticancer agents, and is not only intended for those working as a medical doctor with cancer patients, but also for medical researchers and students. The different classes of anticancer drugs are described by international authorities on the various topics.
Zielgruppe
Research
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Immunologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
- Naturwissenschaften Biowissenschaften Molekularbiologie
Weitere Infos & Material
Antimetabolites.- DNA-intercalators — the anthracyclines.- Topoisomerase inhibitors.- Tubulin interacting agents.- Vaccination therapies in solid tumors.- Oral anticancer agents.- Anti-angiogenesis agents.- Signal transduction inhibitors.- Endocrine therapy of breast cancer.
